Basic info
Industry
biotechnology research
Sectors
Biotechnology
Immuno-oncology
Prostate Cancer
Genome Engineering
Multiple Myeloma
piggyBac® DNA Modification System
Oncology
Cytotoxic T Lymphocytes
Immunotherapy
Genetics
Gene Therapy
Regenerative Medicine
Non-viral
Biopharma
Gene Editing
Cell Therapy
Cas-CLOVER™
piggyBac®
TAL-CLOVER™
T-cells
CAR-T cells
Therapeutics
Poseida
Immunology
Adoptive Cell Therapy
Transposon
Allogeneic
Date founded
2014
Funding rounds raised
Total raised
$142M
from 14 investors over 14 rounds
P
Poseida Therapeutics, Inc. raised $110M on June 25, 2020
Investors: Adage Capital Management
P
Poseida Therapeutics, Inc. raised $142M on April 22, 2019
Investors: PENTWATER CAPITAL MANAGEMENT LP, Aisling Capital, Longitude Capital, Vivo Capital, Rapha Capital Management, LLC, Perceptive Advisors and Malin Corporation plc
P
Poseida Therapeutics, Inc. raised $31M on April 3, 2018
Investors: Malin Corporation plc, Tavistock Group, Vivo Capital and Longitude Capital
P
Poseida Therapeutics, Inc. raised $11M on August 2, 2017
Investors: Malin Corporation plc
P
Poseida Therapeutics, Inc. raised $23M on December 23, 2015
Investors: Malin Corporation plc